Literature DB >> 16470600

Spondyloenchondrodysplasia with spasticity, cerebral calcifications, and immune dysregulation: clinical and radiographic delineation of a pleiotropic disorder.

Raffaele Renella1, Elke Schaefer, Martine LeMerrer, Yasemin Alanay, Nurgun Kandemir, Georg Eich, Teresa Costa, Diana Ballhausen, Eugen Boltshauser, Luisa Bonafé, Andres Giedion, Sheila Unger, Andrea Superti-Furga.   

Abstract

Enchondromas are a feature of several constitutional disorders of bone, and the classification of different nosologic entities is still provisional. Among these disorders, spondyloenchondrodysplasia (SPENCD), as outlined by Schorr et al. [1976], is defined by the presence of radiolucent spondylar and metaphyseal lesions that represent persistence of islands of chondroid tissue within bone. Careful review of radiographic findings is needed to distinguish SPENCD from the many other disorders combining enchondromas with spinal lesions. Even when strict criteria are applied, it appears that SPENCD is clinically heterogeneous, as some SPENCD patients are neurologically intact while others present with spasticity, mental retardation, and cerebral calcifications in different combinations, and it has been suggested that SPENCD should be divided in two types. We herein report ten individuals from six families with SPENCD and illustrate the radiographic changes. Seven individuals had CNS manifestations including spasticity, developmental delay, and late-onset cerebral calcifications. We also noted that six individuals had clinical manifestations of autoimmunity (auto-immune thrombocytopenic purpura, auto-immune hemolytic anemia, auto-immune thyroiditis, and SLE) and one had been diagnosed with immune deficiency. Neurological and autoimmune manifestations were seen in different combinations within one single family. These observations suggest that SPENCD may be a single entity defined by specific radiographic features, but with remarkably pleiotropic manifestations that include CNS disease (spasticity, mental retardation, and calcifications), as well as immune dysregulation ranging from autoimmunity to immunodeficiency. The notion of recessive inheritance hitherto assumed is challenged by the observation of two apparently dominant pedigrees. 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16470600     DOI: 10.1002/ajmg.a.31081

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  16 in total

1.  Response of knee fibrocartilage to joint destabilization.

Authors:  N A Dyment; Y Hagiwara; X Jiang; J Huang; D J Adams; D W Rowe
Journal:  Osteoarthritis Cartilage       Date:  2015-02-11       Impact factor: 6.576

2.  Severe Short Stature in Two Siblings as the Presenting Sign of ACP5 Deficiency.

Authors:  Christiaan de Bruin; Zerrin Orbak; Melissa Andrew; Vivian Hwa; Andrew Dauber
Journal:  Horm Res Paediatr       Date:  2016-01-21       Impact factor: 2.852

3.  Metaphyseal chondromatosis combined with D-2-hydroxyglutaric aciduria in four patients.

Authors:  Hye Jung Choo; Tae-Joon Cho; Junghan Song; George E Tiller; Sun Hee Lee; Gunbo Park; In Sook Lee; Ralph Lachman; Andrea Superti-Furga; Ok-Hwa Kim
Journal:  Skeletal Radiol       Date:  2012-05-26       Impact factor: 2.199

4.  Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity.

Authors:  Ekkehart Lausch; Andreas Janecke; Matthias Bros; Stefanie Trojandt; Yasemin Alanay; Corinne De Laet; Christian A Hübner; Peter Meinecke; Gen Nishimura; Mari Matsuo; Yoshiko Hirano; Sylvie Tenoutasse; Andrea Kiss; Rafael Fabiano Machado Rosa; Sharon L Unger; Raffaele Renella; Luisa Bonafé; Jürgen Spranger; Sheila Unger; Bernhard Zabel; Andrea Superti-Furga
Journal:  Nat Genet       Date:  2011-01-09       Impact factor: 38.330

Review 5.  Monogenic autoimmunity.

Authors:  Mickie H Cheng; Mark S Anderson
Journal:  Annu Rev Immunol       Date:  2012-01-06       Impact factor: 28.527

Review 6.  Enchondromatosis: insights on the different subtypes.

Authors:  Twinkal C Pansuriya; Herman M Kroon; Judith V M G Bovée
Journal:  Int J Clin Exp Pathol       Date:  2010-06-26

Review 7.  Type I interferonopathies--an expanding disease spectrum of immunodysregulation.

Authors:  Min Ae Lee-Kirsch; Christine Wolf; Stefanie Kretschmer; Axel Roers
Journal:  Semin Immunopathol       Date:  2015-05-22       Impact factor: 11.759

8.  Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature.

Authors:  Tracy A Briggs; Gillian I Rice; Sarah Daly; Jill Urquhart; Hannah Gornall; Brigitte Bader-Meunier; Kannan Baskar; Shankar Baskar; Veronique Baudouin; Michael W Beresford; Graeme C M Black; Rebecca J Dearman; Francis de Zegher; Emily S Foster; Camille Francès; Alison R Hayman; Emma Hilton; Chantal Job-Deslandre; Muralidhar L Kulkarni; Martine Le Merrer; Agnes Linglart; Simon C Lovell; Kathrin Maurer; Lucile Musset; Vincent Navarro; Capucine Picard; Anne Puel; Frederic Rieux-Laucat; Chaim M Roifman; Sabine Scholl-Bürgi; Nigel Smith; Marcin Szynkiewicz; Alice Wiedeman; Carine Wouters; Leo A H Zeef; Jean-Laurent Casanova; Keith B Elkon; Anthony Janckila; Pierre Lebon; Yanick J Crow
Journal:  Nat Genet       Date:  2011-01-09       Impact factor: 38.330

9.  Schimke immunoosseous dysplasia: defining skeletal features.

Authors:  Kshamta B Hunter; Thomas Lücke; Jürgen Spranger; Sarah F Smithson; Harika Alpay; Jean-Luc André; Yumi Asakura; Radovan Bogdanovic; Dominique Bonneau; Robyn Cairns; Karlien Cransberg; Stefan Fründ; Helen Fryssira; David Goodman; Knut Helmke; Barbara Hinkelmann; Guiliana Lama; Petra Lamfers; Chantal Loirat; Silvia Majore; Christy Mayfield; Bertram F Pontz; Cristina Rusu; Jorge M Saraiva; Beate Schmidt; Lawrence Shoemaker; Sabine Sigaudy; Natasa Stajic; Doris Taha; Cornelius F Boerkoel
Journal:  Eur J Pediatr       Date:  2009-12-15       Impact factor: 3.183

10.  Severe immune dysregulation with neurological impairment and minor bone changes in a child with spondyloenchondrodysplasia due to two novel mutations in the ACP5 gene.

Authors:  Hermann Girschick; Christine Wolf; Henner Morbach; Christoph Hertzberg; Min Ae Lee-Kirsch
Journal:  Pediatr Rheumatol Online J       Date:  2015-09-07       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.